RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease

Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease

Add to Collection
Review S Nayak, V Rathore, J Bharati… - Expert Review of Clinical …, 2021 - Taylor & Francis

Chapter : Section3
Journal Year : 2021
Cited by : 1.0

… of major ketogenic enzymes even in a non-diabetic setting [60]. Ketogenesis and shift to ketone body utilization as fuel were documented in human subjects without diabetes [61]. …..... Read More

Keywords : ["nondiabetic kidney disease", "inhibitor beyond diabetes", "preclinical study", "review", "extend", "clinical", "ambit"]
PubMed Link : https://www.tandfonline.com/doi/abs/10.1080/17512433.2021.2028620
Google Scholar Link : https://scholar.google.com/scholar?cites=7492831305010944424&as_sdt=5,43&sciodt=0,43&hl=en&num=20